Connect with us

Health

Thai medicines generated Bt80mln ($2.66mln) revenue

Thai medicines have made headway into the ASEAN market, generating around Bt80 million in revenue last year as pharmaceuticals registered in the ASEAN region.

Published

on

Thai medicines have made headway into the ASEAN market, generating around Bt80 million in revenue last year as pharmaceuticals registered in the ASEAN region.

Government Pharmaceutical Organisation GPO Director Dr Vithit Attavechakul said Thailand has advanced in manufacturing medicines for chronic diseases which are widely exported to several ASEAN countries, mainly Cambodia, Myanmar, Laos, and Vietnam.Anti-viral drugs for AIDS, anti-diabetic, and anti high-blood pressure drugs are most popular among all medicines.

Thai medicines plant

Thai medicines generated around Bt80 million in revenue last year as pharmaceuticals registered in the ASEAN region.

 

Dr Vithit said the popularity gained was because consumers were confident of the quality of Thai drugs which are standardised under the GPO and sold both in hospitals and drugstores.

He noted that GPO next week will negotiate with Indonesias equivalent of the Food and Drug Administration to register Thai medicines there. There could also be a joint investment for medications manufacturing in Indonesia.

via Thai medicines penetrate ASEAN market, generating Bt80 mln revenue | MCOT.net.

GPO’s policy is to be the leading domestic drug manufacturer and exporter to the AEC by 2015 in order to accommodate treatment via the country’s public health system and to accommodate free trade for the medicine business and the AEC. Research and development for drug formulas requires bioequivalence and in vitro studies required to represent the efficacy of the drug and to submit for the drug registration to FDA.

The Research and Development Institute, GPO, therefore, established a Bioequivalence Study Center in 2007 by renovating the laboratory and procuring the necessary tools and equipment with a budget of 15 Million Baht in order to apply for Laboratory Quality Standards certification.

At present, GPO is collaborating with a leading Indian Contract Research Organization (CRO) which has provided both clinical research and bioequivalence study services in India, Canada, Poland, the United Kingdom and the United States of America, worked as a consultant for GPO and provided the transfer of the necessary technology to elevate GPO’s Bioequivalence Study Center to a level where it could receive international standard accreditation from organizations such as WHO and EMEA. This is to accommodate the GPO’s new production plant in Rangsit which requires such accreditation.

Click to comment

Leave a Reply

Health

The Role of Telemedicine Today: During and Beyond the COVID-19

Lockdowns, quarantine periods, and hospitals fast filling to the brink needed the medical community to come up with solutions fast. Telemedicine was uniquely placed to help solve many of these problems.

Published

on

By

Before the COVID-19 pandemic that drastically altered what we perceived as our way of life, telemedicine was seen by some as a promising and convenient mode of providing medical care.

(more…)
Continue Reading

Health

Southeast Asia Covid-19 Latest News

The Delta variant has ripped through Southeast Asia in recent weeks, undoing many countries’ progress against the Covid-19 pandemic. Indonesia has been hit especially hard.

Published

on

Coronavirus disease 2019 (COVID-19) WHO Thailand Situation Report - 22 February 2021

The Delta variant has ripped through Southeast Asia in recent weeks, undoing many countries’ progress against the Covid-19 pandemic. Indonesia has been hit especially hard.

(more…)
Continue Reading